Publications

Patent applications

  1. Markers and their use in brain injury. PCT/EP2015/001946
  2. Methods for differentiating ischemic stroke from hemorrhagic stroke. PCT/EP2015/078576
  3. Biomarkers panels for brain injury complications WO2017008894

Relevant scientific publications

  1. Lagerstedt L, Egea-Guerrero JJ, Bustamante A, Rodríguez-Rodríguez A, El Rahal A, Quintana-Diaz M, García-Armengol R, Prica CM, Andereggen E, Rinaldi L, Sarrafzadeh A, Schaller K, Montaner J, Sanchez JC. Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury. PLoS One. 2018 Jul 9;13(7):e0200394. doi: 10.1371/journal.pone.0200394. eCollection 2018. PubMed PMID: 29985933; PubMed Central PMCID: PMC6037378.
  2. Lagerstedt L, Egea-Guerrero JJ, Rodríguez-Rodríguez A, Bustamante A, Montaner J, El Rahal A, Andereggen E, Rinaldi L, Sarrafzadeh A, Schaller K, Sanchez JC. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One. 2018 Feb 21;13(2):e0193278. doi: 10.1371/journal.pone.0193278. eCollection 2018. PubMed PMID: 29466474; PubMed
    Central PMCID: PMC5821397.
  3. García-Berrocoso T, Llombart V, Colàs-Campàs L, Hainard A, Licker V, Penalba A, Ramiro L, Simats A, Bustamante A, Martínez-Saez E, Canals F, Sanchez JC, Montaner J. Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells after Ischemia. Mol Cell Proteomics. 2018 Jan;17(1):175-189. doi: 10.1074/mcp.RA117.000419. Epub 2017 Nov 13. PubMed PMID: 29133510; PubMed Central PMCID: PMC5750846.
  4. Azurmendi L, Lapierre-Fetaud V, Schneider J, Montaner J, Katan M, Sanchez JC. Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study. Clin Proteomics. 2017 Jul 12;14:27. doi: 10.1186/s12014-017-9162-0. eCollection 2017. PubMed PMID: 28701906; PubMed Central PMCID: PMC5506582.
  5. Lagerstedt L, Egea-Guerrero JJ, Bustamante A, Montaner J, Rodríguez-Rodríguez A, El Rahal A, Turck N, Quintana M, García-Armengol R, Prica CM, Andereggen E, Rinaldi L, Sarrafzadeh A, Schaller K, Sanchez JC. H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury. PLoS One. 2017 Apr 18;12(4):e0175572. doi: 10.1371/journal.pone.0175572. eCollection 2017. PubMed PMID: 28419114; PubMed Central PMCID: PMC5395174.
  6. Pearn ML, Niesman IR, Egawa J, Sawada A, Almenar-Queralt A, Shah SB, Duckworth JL, Head BP. Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. Cell Mol Neurobiol. 2016 Jul 6. Review.
  7. Azurmendi L, Degos V, Tiberti N, Kapandji N, Sanchez-Peña P, Sarrafzadeh A, Puybasset L, Turck N, Sanchez JC. Neopterin plasma concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with infection and long-term outcome. J Neurosurg. 2016 May;124(5):1287-99.
  8. Bustamante A, García-Berrocoso T, Rodriguez N, Llombart V, Ribó M, Molina C, Montaner J. Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care. Eur J Intern Med. 2016 Apr;29:9-21.
  9. Simats A, García-Berrocoso T, Montaner J. Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy. Biochim Biophys Acta. 2016 Mar;1862(3):411-24.
  10. Llombart V, García-Berrocoso T, Bustamante A, Giralt D, Rodriguez-Luna D, Muchada M, Penalba A, Boada C, Hernández-Guillamon M, Montaner J. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage. J Neurochem. 2016 Jan;136(2):416-24.
  11. Azurmendi L, Degos V, Tiberti N, Kapandji N, Sanchez P, Sarrafzadeh A, Puybasset L, Turck N, Sanchez JC. Measuring Serum Amyloid A for Infection Prediction in Aneurysmal Subarachnoid Hemorrhage. J Proteome Res. 2015 Sep 4;14(9):3948-56.
  12. Smith CJ, Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, Di Napoli M, Kalra L, Langhorne P, Montaner J, Roffe C, Rudd AG, Tyrrell PJ, van de Beek D, Woodhead M, Meisel A. Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group. Stroke. 2015 Aug;46(8):2335-40.
  13. Walder B, Robin X, Rebetez MM, Copin JC, Gasche Y, Sanchez JC, Turck N. The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with s100b in severe traumatic brain injury. J Neurotrauma. 2013 Oct 1;30(19):1631-7.
  14. Salat D, Penalba A, García-Berrocoso T, Campos-Martorell M, Flores A, Pagola J, Bustamante A, Quintana M, Giralt D, Molina C, Alvarez-Sabín J, Montaner J. Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke. Cerebrovasc Dis. 2013;35(3):220-7

Designed by : COWmotion
Made by : Sur Mesure concept